Coordination and Regulatory support across Europe for an innovative product/orphan drug

Marketing Communication
Regulatory affairs Pharmaceutical industry
Regulatory affairs Pharmaceutical industry
May 12, 2022
  • Drug Development
image_pdfPDF

The Vice-President Global Regulatory Affairs of a US based company developing an important innovative product (orphan drug) contacted BlueReg to seek regulatory support to discuss the different stages of development in Europe.

Our Client Objectives:

  • Understand the pathway towards approval in the proposed market and target therapeutic indication.
  • Anticipate potential discussion highlights with regulators and take advantage of pathways according to product type/category (ATMPS, ODD).
  • Prepare a robust regulatory dossier that details application in order to optimize chance of approval and success.
  • Alignment of EU with US strategy (streamline & capitalize, minimize change & cost).
 

Register to download the Case study

    By sending this form, I agree that my personal data will be saved and processed according to data protection regulations and will be used only for commercial and marketing purposes only.

    Learn more

    BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
    Any inquiries, correction or declaration of event related to personal data processed should be sent to: GDPR data request

    GDPR data request

    Thank you for your interest in BlueReg

    The file will be sent to you by email.

    Download your Case study